Segovia, Samie P.
HRN: 25-69-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2024
CEFTRIAXONE 1G (VIAL)
08/15/2024
08/22/2024
IV
2g
Q24
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes